Sumagang, Jerick .
HRN: 22-44-03 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2023
CEFTRIAXONE 1G (VIAL)
02/18/2023
02/25/2023
IV
450 Mg
Q24
T/C Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Disseminated Systemic Infection Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes